Health-tech startup Sunfox Technologies has successfully raised Rs 15 crore in a pre-Series A funding round led by Venture Catalysts, with additional participation from Finvolve through the IA Growth Opportunities Fund I and Brew Opportunities Fund. Other investors include Universal Group and RP Singhvi Group.
This latest investment follows a Rs 5 crore funding round from USAID through SAMRIDH Health and LetsVenture, and Sunfox’s appearance on Shark Tank India. The newly acquired funds are earmarked for the expansion of the company’s operations both in India and internationally, with a particular focus on scaling its flagship innovation, Spandan, according to the company’s press release.
Founded in 2016 by Rajat Jain, Arpit Jain, Saurabh Badola, Nitin Chandola, and Sabit Rawat, Sunfox Technologies operates as a research and development lab dedicated to advancing healthcare technologies for the digital age. Its primary product, Spandan, is a smartphone-based portable ECG device that delivers clinically accurate 12-lead ECG readings. This enables users to detect heart attacks and monitor cardiac health in real time.
Based in Dehradun, Sunfox claims that Spandan has been utilized by over 30,000 individuals across 20 countries, saving more than 10,000 lives through early detection of heart conditions. The importance of this technology has only increased as India faces a rising incidence of heart attacks in the post-COVID-19 era.
Sunfox has also garnered global recognition from prestigious institutions like Oxford and Wharton, and has established an advanced in-house R&D and manufacturing facility in Dehradun to support its innovative work.
